These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7683467)

  • 1. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors.
    Killian CS; Corral DA; Kawinski E; Constantine RI
    Biochem Biophys Res Commun; 1993 Apr; 192(2):940-7. PubMed ID: 7683467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
    Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
    J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
    Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
    Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
    Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells.
    Takeuchi Y; Fukumoto S; Matsumoto T
    J Cell Physiol; 1995 Mar; 162(3):315-21. PubMed ID: 7860639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen.
    Dallas SL; Zhao S; Cramer SD; Chen Z; Peehl DM; Bonewald LF
    J Cell Physiol; 2005 Feb; 202(2):361-70. PubMed ID: 15389580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
    Kwok S; Qin L; Partridge NC; Selvamurugan N
    J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen induces osteoplastic changes by an autonomous mechanism.
    Yonou H; Aoyagi Y; Kanomata N; Kamijo T; Oda T; Yokose T; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1082-7. PubMed ID: 11741302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cathepsin D and prostate specific antigen on latent transforming growth factor-beta in breast cancer cell lines.
    Wong SF; Seow HF; Lai LC
    Malays J Pathol; 2003 Dec; 25(2):129-34. PubMed ID: 16196369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
    Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of osteoblastic bone metastasis of prostate cancer].
    Yonou H; Ogawa Y; Ochiai A
    Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo.
    Denmeade SR; Litvinov I; Sokoll LJ; Lilja H; Isaacs JT
    Prostate; 2003 Jun; 56(1):45-53. PubMed ID: 12746846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix.
    Morton DM; Barrack ER
    Cancer Res; 1995 Jun; 55(12):2596-602. PubMed ID: 7780974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed electromagnetic field stimulation of MG63 osteoblast-like cells affects differentiation and local factor production.
    Lohmann CH; Schwartz Z; Liu Y; Guerkov H; Dean DD; Simon B; Boyan BD
    J Orthop Res; 2000 Jul; 18(4):637-46. PubMed ID: 11052501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.